Effects of empagliflozin, diet, or both on physical activity and sedentary behaviour in people with type 2 diabetes: analyses from the SEESAW trial [Abstract]
conference contribution
posted on 2020-12-10, 16:33 authored by Jack Sargeant, James KingJames King, Emma Baldry, Danielle Bodicoat, Charlotte Edwardson, Kamlesh Khunti, David StenselDavid Stensel, David Webb, John Wilding, Tom Yates, Melanie DaviesNo description supplied
History
Related Materials
School
- Sport, Exercise and Health Sciences
Published in
DiabetologiaVolume
63Issue
Suppl 1Pages
S270 - S271Article number
564Source
56th Annual Meeting of the European Association for the Study of Diabetes (EASD 2020)Publisher
SpringerVersion
- AM (Accepted Manuscript)
Rights holder
© Springer-Verlag GmbH Germany, part of Springer NaturePublisher statement
This is a post-peer-review, pre-copyedit version of an article published in Diabetologia. The final authenticated version is available online at: https://doi.org/10.1007/s00125-020-05221-5.Acceptance date
2020-05-27Publication date
2020-08-25Copyright date
2020ISSN
0012-186XeISSN
1432-0428Publisher version
Language
- en
Location
ViennaEvent dates
21st September 2020 - 25th September 2020Depositor
Dr James King Deposit date: 27 May 2020Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC